Perrigo (PRGO) EBITDA Margin (QoQ) (2013 - 2026)
Perrigo (PRGO) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 4,071.00 |
| Mar 28, 2026 | 7,758.00 |
| Dec 31, 2025 | -12,296.00 |
| Sep 27, 2025 | 266.00 |
| Jun 28, 2025 | -19.00 |
| Mar 29, 2025 | -554.00 |
| Dec 31, 2024 | 264.00 |
| Sep 28, 2024 | 988.00 |
| Jun 29, 2024 | 261.00 |
| Mar 30, 2024 | -375.00 |
| Dec 31, 2023 | -687.00 |
| Sep 30, 2023 | 77.00 |
| Jul 1, 2023 | 66.00 |
| Apr 1, 2023 | 142.00 |
| Dec 31, 2022 | -33.00 |
| Oct 1, 2022 | 362.00 |
| Jul 2, 2022 | -263.00 |
| Apr 2, 2022 | -221.00 |
| Dec 31, 2021 | -3,781.00 |
| Oct 2, 2021 | 5,487.00 |